markets

Swiss Dental Startup vVARDIS Begins Trading on NYSE Under VVVV

Summarized from All Financial Services & Investing

vVARDIS, a dental biotech targeting cavity treatment without drilling, has gone public on the New York Stock Exchange under the ticker VVVV.

Swiss Dental Startup vVARDIS Begins Trading on NYSE Under VVVV

vVARDIS, a dental biotechnology company co-founded by Dr. Haley Abivardi and Dr. Goly Abivardi, began trading on the New York Stock Exchange on Nov. 13, 2026, under the ticker symbol VVVV, marking a significant milestone for a firm that has staked its growth on a drill-free approach to treating tooth decay.

The company's core proposition targets cavities, which the founders describe as the world's most prevalent non-communicable disease, affecting hundreds of millions of people globally. By pursuing a treatment path that eliminates the drill, vVARDIS is positioning itself against decades of conventional dentistry practice and a large, entrenched industry.

Read more Leverage Shares Launches 2x Long Anthropic ETF as ANT Debuts on Nasdaq →

The public listing gives vVARDIS access to capital markets at a moment when investor appetite for health-focused biotechnology remains a significant driver of IPO activity. The NYSE debut signals the company's intent to scale its technology and commercial reach beyond its founding stage.

The Abivardi co-founders, who bring a scientific and clinical background to the venture, have framed the company's mission in public health terms, arguing that the burden of untreated dental disease represents both a humanitarian and a market opportunity. The IPO puts that thesis to the test before institutional and retail investors alike.

Continue reading at All Financial Services & Investing.

Frequently Asked Questions

Q.What does vVARDIS do and what is its NYSE ticker symbol?

vVARDIS is a dental biotechnology company focused on drill-free treatment for cavities. It trades on the New York Stock Exchange under the ticker symbol VVVV.

Q.Who founded vVARDIS?

vVARDIS was co-founded by Dr. Haley Abivardi and Dr. Goly Abivardi.

Q.Why does vVARDIS describe cavities as the world's number one non-communicable disease?

The company's founders characterize tooth decay as the world's most widespread non-communicable disease, citing its global prevalence as the central public health problem their drill-free technology is designed to address.

More in markets →